1. Home
  2. CCO vs RAPP Comparison

CCO vs RAPP Comparison

Compare CCO & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clear Channel Outdoor Holdings Inc.

CCO

Clear Channel Outdoor Holdings Inc.

HOLD

Current Price

$2.08

Market Cap

1.0B

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$29.64

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCO
RAPP
Founded
1995
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2005
2024

Fundamental Metrics

Financial Performance
Metric
CCO
RAPP
Price
$2.08
$29.64
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
$2.10
$47.80
AVG Volume (30 Days)
2.2M
375.1K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,569,344,000.00
N/A
Revenue This Year
$6.76
N/A
Revenue Next Year
$4.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
54.21
N/A
52 Week Low
$0.81
$6.43
52 Week High
$2.09
$42.27

Technical Indicators

Market Signals
Indicator
CCO
RAPP
Relative Strength Index (RSI) 64.60 55.68
Support Level $2.00 $28.03
Resistance Level $2.09 $31.52
Average True Range (ATR) 0.07 1.95
MACD -0.00 0.00
Stochastic Oscillator 90.63 59.02

Price Performance

Historical Comparison
CCO
RAPP

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: